Exploring Dual-Targeted Therapy in the Management of Moderate to Severe Inflammatory Bowel Disease: A Retrospective Study

被引：0

作者：

Bhaskar, Sonya ^{[1
]}

Makovich, Zachary ^{[2
]}

Coughlin, Emily ^{[1
]}

Mhaskar, Rahul ^{[1
]}

Seminerio, Jennifer L. ^{[2
]}

机构：

[1] Univ S Florida, Tampa, FL USA

[2] Univ S Florida, Morsani Coll Med, Tampa, FL USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期

关键词：

D O I：

10.14309/01.ajg.0001034136.41707.fa

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1192

引用

页码：S847 / S847

页数：1

共 50 条

[21] Inflammatory Bowel Disease: A Retrospective Study [J].

Radhi, Qasim Razaq ;

Al-Qamish, Jehad Radhi .

BAHRAIN MEDICAL BULLETIN, 2011, 33 (02) :72-77

[22] Severe inflammatory bowel disease: Medical management [J].

Farthing, MJG .

DIGESTIVE DISEASES, 2003, 21 (01) :46-53

[23] Pharmacotherapy for Moderate to Severe Inflammatory Bowel Disease: Evolving Strategies [J].

Love, Bryan L. .

AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (03) :S39-S50

[24] Dual-targeted therapy with Certolizumab and Risankizumab for the treatment of Crohn's disease and spondylarthritis [J].

Lehmann, Anouk ;

Niess, Jan Hendrik .

SWISS MEDICAL WEEKLY, 2023, 153 :29S-30S

[25] Interleukin 2 targeted therapy in inflammatory bowel disease [J].

Yarkoni, S. ;

Sagiv, Y. ;

Kaminitz, A. ;

Askenasy, N. .

GUT, 2009, 58 (12) :1705-1706

[26] Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease [J].

Miyatani, Yusuke ;

Choi, David ;

Choi, Natalie K. ;

Rubin, David T. .

DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (02) :355-359

[27] Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn’s Disease [J].

Yusuke Miyatani ;

David Choi ;

Natalie K. Choi ;

David T. Rubin .

Digestive Diseases and Sciences, 2024, 69 :355-359

[28] A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer's disease [J].

Zhao, Dongju ;

Tang, Yuqing ;

Suo, Xinjun ;

Zhang, Chaonan ;

Dou, Yan ;

Chang, Jin .

INNOVATION, 2021, 2 (04)

[29] Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA [J].

Gomez-Labrador, Celia ;

Ricart, Elena ;

Iborra, Marisa ;

Iglesias, Eva ;

Martin-Arranz, Maria Dolores ;

de Castro, Luisa ;

De Francisco, Ruth ;

Garcia-Alonso, Francisco Javier ;

Sanahuja, Ana ;

Gargallo-Puyuelo, Carla J. ;

Mesonero, Francisco ;

Casanova, Maria Jose ;

Manosa, Miriam ;

Rivero, Montserrat ;

Calvo, Marta ;

Sierra-Ausin, Monica ;

Gonzalez-Munoza, Carlos ;

Calvet, Xavier ;

Garcia-Lopez, Santiago ;

Guardiola, Jordi ;

Garcia, Lara Arias ;

Marquez-Mosquera, Lucia ;

Gutierrez, Ana ;

Zabana, Yamile ;

Navarro-Llavat, Merce ;

Poyatos, Rufo Lorente ;

Piqueras, Marta ;

Torrealba, Leyanira ;

Bermejo, Fernando ;

Ponferrada-Diaz, Angel ;

Perez-Calle, Jose L. ;

Barreiro-de Acosta, Manuel ;

Tejido, Coral ;

Cabriada, Jose Luis ;

Marin-Jimenez, Ignacio ;

Roncero, Oscar ;

Ber, Yolanda ;

Fernandez-Salazar, Luis ;

Aler, Blau Camps ;

Lucendo, Alfredo J. ;

Llao, Jordina ;

Bujanda, Luis ;

Villafranca, Carmen Munoz ;

Domenech, Eugeni ;

Chaparro, Maria ;

Gisbert, Javier P. .

PHARMACEUTICS, 2024, 16 (05)

[30] Engineered Probiotics Enable Targeted Gut Delivery of Dual Gasotransmitters for Inflammatory Bowel Disease Therapy [J].

Ma, Tengfei ;

Gan, Guihai ;

Cheng, Jian ;

Shen, Zhiqiang ;

Zhang, Guoying ;

Liu, Shiyong ;

Hu, Jinming .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 64 (22)

← 1 2 3 4 5 →